Merck already sells an older pneumococcal vaccine called Pneumovax 23, which protects against 23 strains but is a polysaccharide based shot, so doesn't stimulate as strong an immune response as ...

Ligand Pharmaceuticals offers biotech exposure with reduced risk through its royalty platform. Discover why its valuation now ...

Dominance of the pneumococcal vaccine category is a race between Merck & Co and Pfizer, and while the latter is comfortably in front at the moment with its Prevnar franchise, Merck has multiple ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the company inked with Austria-based drug delivery technology maker Cyprumed ...

While AbbVie also markets products for aesthetics, neuroscience and eye care, Merck has a presence in vaccines, neuroscience diabetes, virology and animal health areas. Oncology accounts for ...

In addition to increasing vaccine coverage in older adults, they need to monitor the changing epidemiology of pneumococcal serotypes causing invasive disease. [134] In the face of these changes ...

Megyn Kelly, the American journalist, regrets her decision to get the Covid-19 vaccine, citing an autoimmune diagnosis following her Pfizer doses and booster. She expressed frustration over the ...

Kennedy Jr., experts looked poised to change policies around vaccines that defend against ... potential blows to companies such as Pfizer and Merck & Co. The ACIP will vote on both subjects ...

(Reuters) -Merck said on Monday the U.S. Food and Drug Administration has approved its next-generation vaccine to protect adults ...

In this article, we are going to take a look at where Merck & Co. Inc. (NYSE:MRK) stands against other high growth forever dividend stocks. Dividend stocks have trailed the broader market over the ...